Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
12.2M
-
Shares change
-
+5.77M
-
Total reported value, excl. options
-
$92.7M
-
Value change
-
+$44M
-
Put/Call ratio
-
1.07
-
Number of buys
-
9
-
Number of sells
-
-11
-
Price
-
$7.62
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q3 2018
33 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q3 2018.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.2M shares
of 71.9M outstanding shares and own 16.92% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (5.9M shares), ORBIMED ADVISORS LLC (2.84M shares), RENAISSANCE TECHNOLOGIES LLC (2.45M shares), Neumann Advisory Hong Kong Ltd (375K shares), STATE STREET CORP (123K shares), Invesco Ltd. (81.3K shares), Yorktown Management & Research Co Inc (69.8K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (68.7K shares), Eqis Capital Management, Inc. (43.9K shares), and Spark Investment Management LLC (39.6K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.